Clinical Trial Update: Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 study assessing low-dose chemotherapy plus sorafenib as initial therapy for advanced non-squamous non-small cell lung cancer was terminated, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: Francisco Robert,MD | Conditions: Non Squamous Cell Lung Cancer, Non Small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2013-06-19